V

Veracyte
D

VCYT

43.090
USD
-0.55
(-1.26%)
مغلق
حجم التداول
23,521
الربح لكل سهم
1
العائد الربحي
-
P/E
-331
حجم السوق
3,339,459,014
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    NEOUSD
    NEOUSD
    -0.476
    (-3.27%)
    14.016 USD
    C
    CDNA
    0.538
    (2.38%)
    23.178 USD
    E
    EXAS
    0.520
    (0.96%)
    54.780 USD
    F
    FGEN
    -0.02950
    (-5.49%)
    0.50740 USD
    G
    GH
    2.070
    (4.59%)
    47.180 USD
    ILMN
    ILMN
    -1.005
    (-0.71%)
    140.300 USD
    N
    NEO
    0.320
    (2.26%)
    14.505 USD
    R
    RGEN
    -1.170
    (-0.70%)
    166.730 USD
    T
    TDOC
    0.38500
    (4.06%)
    9.87500 USD
    T
    TNDM
    -0.370
    (-1.05%)
    35.000 USD
    V
    VEEV
    5.920
    (2.65%)
    229.110 USD
    المزيد
الأخبار
المقالات

العنوان: Veracyte

القطاع: Healthcare
الصناعة: Diagnostics & Research
Veracyte Inc is a genomic diagnostics company. It provides genomic diagnostic products and services to improve patient care against diseases such as thyroid cancer, lung cancer, and idiopathic pulmonary fibrosis. The firm's product portfolio consists of products such as Afirma analysis, Percepta, Envisia, and others.